Surgery for lung cancer that has spread to the lining of the lung
Part of Cancer, Lungs & breathing clinical trials.
This trial tests if removing the main lung tumor can help patients whose cancer has spread to the lining of the lung (M1a stage) but not to other organs. It is for people who have not had any prior treatment for lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 80 years old
- You must be able to perform daily activities with little or no help (ECOG 0 or 1)
- You have not had surgery for lung cancer before
- Your lung cancer is found to have spread only to the lining of the lung (M1a stage) during surgery
- You have not received any radiation or chemotherapy for lung cancer yet
- Your surgeon believes all visible cancer can be removed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This trial tests whether combining chemo or targeted therapy before surgery can help people with non-small cell lung cancer that may require removing a whole lung. We want to see if this approach makes the surgery safer and more effective.
This study looks at whether removing lymph nodes from the opposite side of the chest during surgery can help people with advanced lung cancer that has spread to the lymph nodes in the middle of the chest. It may offer a more thorough treatment for patients who are healthy enough for surgery.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This trial studies whether adding chemotherapy after surgery helps people with early-stage lung adenocarcinoma that has a micropapillary pattern. It’s testing whether chemotherapy given after complete tumor removal can improve outcomes compared with surgery alone.
Hear when a new Surgical Resection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.